New FDA Guidelines Ease Access to Abortion Drug

WASHINGTON—Federal regulators on Wednesday issued new recommendations on drug-induced abortions that may make it easier for women in some states to obtain the procedure, a move that comes at a particularly charged moment in the national debate. The Food and Drug Administration said it would change the label for mifepristone, the main pill used in the procedure, in a way that would effectively sidestep state laws aimed at restricting drug-induced abortion. While FDA guidelines for the use of drugs aren’t binding, a...

Read article